*Based on third-party studies, internal testing and data from commercial installations
REVOLUTIONARY PROTECTION AGAINST VIRUSES, BACTERIA, MOLDS, YEASTS, AND POLLENS
* Based on third-party studies, internal testing, and data from commercial installations
Who We Are
C-POLAR Technologies, Inc. provides biodefense solutions. Our patent-pending technology, C-POLAR™, captures, inactivates, and eradicates up to 99.99% of viruses, bacteria, molds, yeasts, and pollens.*
We create infection-resilient environments, setting the global standard for health and safety for governments, private enterprises, hospitals, and schools.
*Based on third-party studies, internal testing, and data from commercial installations
Trusted By Global Organizations
The National Health Service (NHS) is the United Kingdom's publicly-funded healthcare system.
JONES LANG LASALLE
Jones Lang LaSalle is one of the largest property developers globally.
MIAMI INTERNATIONAL AIRPORT
Miami International Airport is one of the largest airports in North America.
THE GRAND HYATT HK
The Grand Hyatt HK is a five-star, luxury hotel with branches across the world.
HANG LUNG PROPERTIES
Hang Lung Properties is a leading property developer in Hong Kong and Mainland China.
AFL-CIO, METAL TRADES
The Metal Trades Department is part of the AFL-CIO, the largest federation of US unions.
Proven Effective Against
MECHANISM OF ACTION
C-POLAR™ is created using a WHO and UN FAO approved food-additive. Using our patent-pending, proprietary methodology, we apply C-POLAR™ onto selected materials, imbuing them with a stable positive charge. Multiple studies have shown that C-POLAR™ treated materials effectively capture, inactivate, and eradicate viruses, microorganisms, and pollens with high efficiency.
C-POLAR™ is based on fundamental physics. Studies show C-POLAR™ can capture, inactivate, and eradicate up to 99.99% of viruses, microorganisms, and pollens.
Quote from Dr. MICHAEL K. Mansour
“C-POLAR™ treated material demonstrates the eradication of a wide variety of pathogens. The utilization of C-POLAR™ is an essential interrupter, breaking the chain of infectious spread, reducing infection in many applications while improving overall health.”
Dr. Michael K. Mansour
Massachusetts General Hospital - Harvard Medical School
President, Metal Trades Department
"When we tested C-POLAR™ at our HQ in Washington DC, the results were astonishing, greatly reducing particulates, eradicating microorganisms and pollen, and providing a far safer environment for our workers."
“Our team confirms that the antiviral layer used in the production of the FFP3 mask is supplied by C-POLAR™. [This] layer has been proven to kill COVID-19 on contact and is non-allergenic.”
“We have been at the forefront of adopting safety and infection control measures. We are excited to further enhance our protection through using proven technology [such as C-POLAR]”